OncoBay represents an exciting new approach to clinical trials – custom-curated CRO solutions that provide experienced specialists, a highly trained site network and the vast expertise of one of the nation’s leading cancer treatment centers. In addition, your trial will benefit from transparent project pricing and the responsive oversight of a dedicated team who will be serving you every step along the way.
Innovative and Efficient Process
OncoBay Clinical powers clinical trials that are expertly managed to maximize results and minimize time and costs.
We employ comprehensive technological solutions with advanced clinical oversight and integrated data review, reporting and analysis capabilities to ensure accuracy, efficiency and quality. This yields a scientifically based clinical review for every project.
With customized strategic and tactical solutions, OncoBay’s focused immuno-oncology approach has been specifically designed to provide ongoing and transparent risk analysis and mitigation.
OncoBay Clinical is a subsidiary of Moffitt Cancer Center, an internationally known leader in cancer treatment and research. We can leverage the unrivaled support of their top scientific advisors to help you design the most efficient plan for developing your asset.
OncoBay also partners with Moffitt’s integrated cell manufacturing capabilities resulting in “vein-to-vein” control for your clinical trial.
The immuno-oncology development space is evolving, and OncoBay Clinical can help you ensure your IO asset meets clinical development goals both today and in the future. Specializing in immuno-oncology clinical trials, our company boasts a respected team of executive leaders with over 100 years of oncology operations experience.
Every team member is experienced in IO, and because we are a smaller firm, you are not separated from critical experience by deep layers of organizational infrastructure. You have access to a responsive and expert team that is dedicated to your clinical trial from start to finish.